MAIA Stock Analysis: Buy, Sell, or Hold?
MAIA - MAIA Biotechnology, Inc.
$1.42
-0.02 (-1.39%)
▼
5d:
-2.74%
30d:
+11.81%
90d:
+10.94%
BUY
HIGH Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 10, 2026
26d
Get Alerted When MAIA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MAIA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: MAIA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$1.26
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$0.78
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 0.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MAIA is currently trading at $1.42, which is considered fair relative to its 30-day fair value range of $1.32 to $1.46. From a valuation perspective, the stock is trading at a premium (Forward PE: 1.3) compared to its historical average (0.8). At these levels, the market is pricing in 16.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MAIA is in a strong downtrend. Immediate support is located at $1.26, while resistance sits at $1.56.
Market Sentiment: MAIA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.13 (+754.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MAIA is in a strong downtrend. Immediate support is located at $1.26, while resistance sits at $1.56.
Market Sentiment: MAIA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.13 (+754.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.32 -
$1.46
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.4%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 754.6% below Wall St target ($12.13)
- NEUTRAL: Trading at premium valuation - market expects 16.9% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$1.32 -
$1.46
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.26
Resistance Level
$1.56
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.27
Wall Street Target
$12.14
(+754.6%)
Valuation Premium vs History
+16.9% premium
PE vs Historical
1.3 vs 0.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+16.9%
(market-implied from PE analysis)
1-Year Target
$1.66
(+17%)
2-Year Target
$1.94
(+37%)
3-Year Target
$2.27
(+60%)
3-Yr Target (if PE normalizes)
(PE: 1→1)
PE COMPRESSION
$1.43
(+1%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: July 14, 2026 9:16 AM ET
Data refreshes hourly during market hours. Next update: 10:16 AM
Data refreshes hourly during market hours. Next update: 10:16 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MAIA showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 57 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 57 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 60 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$111 | 57 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 62 BUY |
